Knowledge in schizophrenia: The Portuguese version of KAST (Knowledge About Schizophrenia Test) and analysis of social-demographic and clinical factors’ influence
Functional disconnection between the visual cortex and the sensorimotor cortex suggests a potential mechanism for self-disorder in schizophrenia
Saliva secretion disorder in a schizophrenic patient – a problem in dental and psychiatric treatment: a case report
Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia
Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis
Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double-blind continuation study
Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012–2013
Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials
Correspondence of DNA Methylation Between Blood and Brain Tissue and its Application to Schizophrenia Research
Adolescent testosterone influences BDNF and TrkB mRNA and neurotrophin–interneuron marker relationships in mammalian frontal cortex
mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample
Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course
Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia
Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia
Stigma as a stressor and transition to schizophrenia after one year among young people at risk of psychosis
Targeting negative symptoms in schizophrenia: Results from a proof-of-concept trial assessing prefrontal anodic tDCS protocol
Reward System Dysfunction as a Neural Substrate of Symptom Expression Across the General Population and Patients With Schizophrenia
Genetic variants in long non-coding RNA contribute to risk of paranoid schizophrenia in a Chinese Han population
Increased short-range and long-range functional connectivity in first-episode, medication-naive schizophrenia at rest
Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions
Assessment of Lifespan Functioning Attainment (ALFA) Scale: a quantitative interview for self-reported current and functional decline in schizophrenia
Challenging the need for sustained blockade of dopamine D receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study
Connectome organization is related to longitudinal changes in general functioning, symptoms and IQ in chronic schizophrenia
Glycinamide prevents MK-801-induced hyperactivity and deficits in object recognition memory in an animal model of positive and cognitive symptoms of schizophrenia
Age at onset mixture analysis and systematic comparison in schizophrenia spectrum disorders: Is the onset heterogeneity dependent on heterogeneous diagnosis?
Attention/vigilance in schizophrenia: Performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS)
Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients
Beliefs about the causes of schizophrenia among Aymara and non-Aymara patients and their primary caregivers in the Central-Southern Andes
Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population
Treatment with Anti-Toxoplasmic Activity (TATA) for Toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study
A Phase II study of a histamine H receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
Integration of gene expression and GWAS results supports involvement of calcium signaling in Schizophrenia
A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial